Drug Use Investigation for LAMICTAL

Trial Profile

Drug Use Investigation for LAMICTAL

Phase of Trial: Phase IV

Latest Information Update: 14 Nov 2016

At a glance

  • Drugs Lamotrigine (Primary)
  • Indications Lennox-Gastaut syndrome; Partial epilepsies; Tonic-clonic epilepsy
  • Focus Adverse reactions
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 08 Nov 2016 Status changed from active, no longer recruiting to completed.
    • 19 Apr 2015 Planned End Date changed from 1 May 2016 to 1 Aug 2016 as reported by ClinicalTrials.gov.
    • 08 Jun 2014 Planned End Date changed from 1 Apr 2016 to 1 May 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top